Molecular targets and cancer therapeutics.
Serfass
Lucile
L
Van Herpen
Carla
C
Saghatchian
Mahasti
M
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage; D019496:Cancer Vaccines / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D054736:Elongation Factor 2 Kinase / Q000037:antagonists & inhibitors; D023281:Genomics / Q000639:trends; D006801:Humans; D008279:Magnetic Resonance Imaging; D009362:Neoplasm Metastasis / Q000628:therapy; D009369:Neoplasms / Q000235:genetics / Q000628:therapy*
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D019496:Cancer Vaccines; D054736:Elongation Factor 2 Kinase